Linking Stress to Inflammation

Anesthesiology Clinics of North America

Volumn 24, Issue 2, 2006, Pages 325-340

  Bierhaus, Angelika ^a   Humpert, Per M ^a   Nawroth, Peter P ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HUMANS; INFLAMMATION; STRESS, PSYCHOLOGICAL;

EID: 33646519867     PISSN: 08898537     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atc.2006.01.001     Document Type: Review

References (124)

1. Tappy L., Seematter G., and Martin J.L. Environmental influences on diseases in later life. Nestle Nutr Workshop Ser Clin Perform Programme (2004) 19-30 [discussion: 30-15]
2. Mercurio F., and Manning A.M. NF-kappaB as a primary regulator of the stress response. Oncogene 18 (1999) 6163-6171
3. Xiao C., and Ghosh S. NF-kappaB, an evolutionarily conserved mediator of immune and inflammatory responses. Adv Exp Med Biol 560 (2005) 41-45
4. Barnes P.J., and Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336 (1997) 1066-1071
5. Bohrer H., Qiu F., Zimmermann T., et al. Role of NFkappaB in the mortality of sepsis. J Clin Invest 100 (1997) 972-985
6. Neurath M.F., and Pettersson S. Predominant role of NF-kappa B p65 in the pathogenesis of chronic intestinal inflammation. Immunobiology 198 (1997) 91-98
7. Thiele K., Bierhaus A., Autschbach F., et al. Cell specific effects of glucocorticoid treatment on the NF-kappaBp65/IkappaBalpha system in patients with Crohn's disease. Gut 45 (1999) 693-704
8. Valen G., Yan Z.Q., and Hansson G.K. Nuclear factor kappa-B and the heart. J Am Coll Cardiol 38 (2001) 307-314
9. Hofmann M.A., Schiekofer S., Isermann B., et al. Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kappaB. Diabetologia 42 (1999) 222-232
10. Hofmann M.A., Schiekofer S., Kanitz M., et al. Insufficient glycemic control increases nuclear factor-kappa B binding activity in peripheral blood mononuclear cells isolated from patients with type 1 diabetes. Diabetes Care 21 (1998) 1310-1316
11. Evans J.L., Goldfine I.D., Maddux B.A., et al. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 23 (2002) 599-622
12. Mohamed A.K., Bierhaus A., Schiekofer S., et al. The role of oxidative stress and NF-kappaB activation in late diabetic complications. Biofactors 10 (1999) 157-167
13. Mattson M.P., and Camandola S. NF-kappaB in neuronal plasticity and neurodegenerative disorders. J Clin Invest 107 (2001) 247-254
14. Bierhaus A., and Nawroth P.P. Modulation of the vascular endothelium during infection-the role of NF-kappa B activation. Contrib Microbiol 10 (2003) 86-105
15. Bierhaus A., Haslbeck K.M., Humpert P.M., et al. Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily. J Clin Invest 114 (2004) 1741-1751
16. Bierhaus A., Wolf J., Andrassy M., et al. A mechanism converting psychosocial stress into mononuclear cell activation. Proc Natl Acad Sci U S A 100 (2003) 1920-1925
17. Kirschbaum C., Pirke K.M., and Hellhammer D.H. The 'Trier Social Stress Test'-a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 28 (1993) 76-81
18. Kawakami N., Takatsuka N., Shimizu H., et al. Depressive symptoms and occurrence of type 2 diabetes among Japanese men. Diabetes Care 22 (1999) 1071-1076
19. Nakata A., Haratani T., Takahashi M., et al. Job stress, social support, and prevalence of insomnia in a population of Japanese daytime workers. Soc Sci Med 59 (2004) 1719-1730
20. Rosengren A., Hawken S., Ounpuu S., et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case-control study. Lancet 364 (2004) 953-962
21. Keltikangas-Jarvinen L., Kettunen J., Ravaja N., et al. Inhibited and disinhibited temperament and autonomic stress reactivity. Int J Psychophysiol 33 (1999) 185-196
22. Kawakami N., Araki S., Takatsuka N., et al. Overtime, psychosocial working conditions, and occurrence of non-insulin dependent diabetes mellitus in Japanese men. J Epidemiol Community Health 53 (1999) 359-363
23. Keltikangas-Jarvinen L., Ravaja N., and Viikari J. Identifying Cloninger's temperament profiles as related to the early development of the metabolic cardiovascular syndrome in young men. Arterioscler Thromb Vasc Biol 19 (1999) 1998-2006
24. Padgett D.A., and Glaser R. How stress influences the immune response. Trends Immunol 24 (2003) 444-448
25. Felten S.Y., Felten D.L., Bellinger D.L., et al. Noradrenergic and peptidergic innervation of lymphoid organs. Chem Immunol 52 (1992) 25-48
26. Raison C.L., and Miller A.H. When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am J Psychiatry 160 (2003) 1554-1565
27. Vallejo M. Transcriptional control of gene expression by cAMP-response element binding proteins. J Neuroendocrinol 6 (1994) 587-596
28. Todd P.K., and Mack K.J. Phosphorylation, CREB, and mental retardation. Pediatr Res 50 (2001) 672
29. Johnson J.D., Campisi J., Sharkey C.M., et al. Catecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines. Neuroscience 135 (2005) 1295-1307
30. Elenkov I.J., Iezzoni D.G., Daly A., et al. Cytokine dysregulation, inflammation and well-being. Neuroimmunomodulation 12 (2005) 255-269
31. Hosoi T., Okuma Y., and Nomura Y. The mechanisms of immune-to-brain communication in inflammation as a drug target. Curr Drug Targets Inflamm Allergy 1 (2002) 257-262
32. Heinz A., Hermann D., Smolka M.N., et al. Effects of acute psychological stress on adhesion molecules, interleukins and sex hormones: implications for coronary heart disease. Psychopharmacology (Berl) 165 (2003) 111-117
33. Steptoe A., Willemsen G., Owen N., et al. Acute mental stress elicits delayed increases in circulating inflammatory cytokine levels. Clin Sci (Lond) 101 (2001) 185-192
34. Maes M., Van Der Planken M., Van Gastel A., et al. Influence of academic examination stress on hematological measurements in subjectively healthy volunteers. Psychiatry Res 80 (1998) 201-212
35. von Kanel R., Kudielka B.M., Hanebuth D., et al. Different contribution of interleukin-6 and cortisol activity to total plasma fibrin concentration and to acute mental stress-induced fibrin formation. Clin Sci (Lond) 109 (2005) 61-67
36. Brydon L., Edwards S., Mohamed-Ali V., et al. Socioeconomic status and stress-induced increases in interleukin-6. Brain Behav Immun 18 (2004) 281-290
37. Brydon L., and Steptoe A. Stress-induced increases in interleukin-6 and fibrinogen predict ambulatory blood pressure at 3-year follow-up. J Hypertens 23 (2005) 1001-1007
38. Hiscott J., Marois J., Garoufalis J., et al. Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop. Mol Cell Biol 13 (1993) 6231-6240
39. Frangogiannis N.G., Smith C.W., and Entman M.L. The inflammatory response in myocardial infarction. Cardiovasc Res 53 (2002) 31-47
40. Fraser J.K., Lill M.C., and Figlin R.A. The biology of the cytokine sequence cascade. Semin Oncol 23 (1996) 2-8
41. Brydon L., Edwards S., Jia H., et al. Psychological stress activates interleukin-1beta gene expression in human mononuclear cells. Brain Behav Immun 19 (2005) 540-546
42. Avitsur R., Kavelaars A., Heijnen C., et al. Social stress and the regulation of tumor necrosis factor-alpha secretion. Brain Behav Immun 19 (2005) 311-317
43. Goebel M.U., Mills P.J., Irwin M.R., et al. Interleukin-6 and tumor necrosis factor-alpha production after acute psychological stress, exercise, and infused isoproterenol: differential effects and pathways. Psychosom Med 62 (2000) 591-598
44. Murray D.R., Prabhu S.D., and Chandrasekar B. Chronic beta-adrenergic stimulation induces myocardial proinflammatory cytokine expression. Circulation 101 (2000) 2338-2341
45. Zhou M., Yang S., Koo D.J., Ornan D.A., et al. The role of Kupffer cell alpha(2)-adrenoceptors in norepinephrine-induced TNF-alpha production. Biochim Biophys Acta 1537 (2001) 49-57
46. Papanicolaou D.A., Wilder R.L., Manolagas S.C., et al. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 128 (1998) 127-137
47. Lee D.L., Leite R., Fleming C., et al. Hypertensive response to acute stress is attenuated in interleukin-6 knockout mice. Hypertension 44 (2004) 259-263
48. Goebel M.U., and Mills P.J. Acute psychological stress and exercise and changes in peripheral leukocyte adhesion molecule expression and density. Psychosom Med 62 (2000) 664-670
49. Mills P.J., and Dimsdale J.E. The effects of acute psychologic stress on cellular adhesion molecules. J Psychosom Res 41 (1996) 49-53
50. Mills P.J., Farag N.H., Hong S., et al. Immune cell CD62L and CD11a expression in response to a psychological stressor in human hypertension. Brain Behav Immun 17 (2003) 260-267
51. Redwine L., Snow S., Mills P., and Irwin M. Acute psychological stress: effects on chemotaxis and cellular adhesion molecule expression. Psychosom Med 65 (2003) 598-603
52. McEver R.P. Adhesive interactions of leukocytes, platelets, and the vessel wall during hemostasis and inflammation. Thromb Haemost 86 (2001) 746-756
53. Redwine L., Mills P.J., Sada M., et al. Differential immune cell chemotaxis responses to acute psychological stress in Alzheimer caregivers compared to non-caregiver controls. Psychosom Med 66 (2004) 770-775
54. Dhabhar F.S., and McEwen B.S. Acute stress enhances while chronic stress suppresses cell-mediated immunity in vivo: a potential role for leukocyte trafficking. Brain Behav Immun 11 (1997) 286-306
55. Viswanathan K., and Dhabhar F.S. Stress-induced enhancement of leukocyte trafficking into sites of surgery or immune activation. Proc Natl Acad Sci U S A 102 (2005) 5808-5813
56. Larson M.R., Ader R., and Moynihan J.A. Heart rate, neuroendocrine, and immunological reactivity in response to an acute laboratory stressor. Psychosom Med 63 (2001) 493-501
57. Dhabhar F.S. Stress, leukocyte trafficking, and the augmentation of skin immune function. Ann N Y Acad Sci 992 (2003) 205-217
58. Bierhaus A., and Nawroth P.P. [Coagulation, inflammation and immune response-an evolutionary conserved plan as cause for disseminated intravasal coagulation?]. Hamostaseologie 25 (2005) 23-32 [in German]
59. von Kanel R., Mills P.J., Ziegler M.G., et al. Effect of beta2-adrenergic receptor functioning and increased norepinephrine on the hypercoagulable state with mental stress. Am Heart J 144 (2002) 68-72
60. Begbie M., Notley C., Tinlin S., et al. The factor VIII acute phase response requires the participation of NFkappaB and C/EBP. Thromb Haemost 84 (2000) 216-222
61. Yamamoto K., Shimokawa T., Yi H., et al. Aging and obesity augment the stress-induced expression of tissue factor gene in the mouse. Blood 100 (2002) 4011-4018
62. von Kanel R., Kudielka B.M., Preckel D., et al. Opposite effect of negative and positive affect on stress procoagulant reactivity. Physiol Behav 86 (2005) 61-68
63. von Kanel R., Dimsdale J.E., Patterson T.L., et al. Acute procoagulant stress response as a dynamic measure of allostatic load in Alzheimer caregivers. Ann Behav Med 26 (2003) 42-48
64. Fenga C., Micali E., Cacciola A., et al. Stressful life events and fibrinogen level in middle-aged teachers. Psychopathology 37 (2004) 64-68
65. von Kanel R., Preckel D., Zgraggen L., et al. The effect of natural habituation on coagulation responses to acute mental stress and recovery in men. Thromb Haemost 92 (2004) 1327-1335
66. Minami T., Abid M.R., Zhang J., et al. Thrombin stimulation of vascular adhesion molecule-1 in endothelial cells is mediated by protein kinase C (PKC)-delta-NF-kappa B and PKC-zeta-GATA signaling pathways. J Biol Chem 278 (2003) 6976-6984
67. Strukova S. Blood coagulation-dependent inflammation: coagulation-dependent inflammation and inflammation-dependent thrombosis. Front Biosci 11 (2006) 59-80
68. Chu A.J. Tissue factor mediates inflammation. Arch Biochem Biophys 440 (2005) 123-132
69. Strike P.C., Magid K., Brydon L., et al. Exaggerated platelet and hemodynamic reactivity to mental stress in men with coronary artery disease. Psychosom Med 66 (2004) 492-500
70. Vrijkotte T.G., van Doornen L.J., and de Geus E.J. Work stress and metabolic and hemostatic risk factors. Psychosom Med 61 (1999) 796-805
71. Kop W.J., Hamulyak K., Pernot C., et al. Relationship of blood coagulation and fibrinolysis to vital exhaustion. Psychosom Med 60 (1998) 352-358
72. von Kanel R., Frey K., and Fischer J. Independent relation of vital exhaustion and inflammation to fibrinolysis in apparently healthy subjects. Scand Cardiovasc J 38 (2004) 28-32
73. Ishizaki M., Tsuritani I., Noborisaka Y., et al. Relationship between job stress and plasma fibrinolytic activity in male Japanese workers. Int Arch Occup Environ Health 68 (1996) 315-320
74. Graver V., Haaland A.K., Loeb M., et al. Fibrinolytical activity in relation to psychological traits in patients with sciatica. Thromb Res 85 (1997) 363-366
75. Hevey D., McGee H.M., Fitzgerald D., et al. Acute psychological stress decreases plasma tissue plasminogen activator (tPA) and tissue plasminogen activator/plasminogen activator inhibitor-1 (tPA/PAI-1) complexes in cardiac patients. Eur J Appl Physiol 83 (2000) 344-348
76. Mangiafico R.A., Malatino L.S., Attina T., et al. Exaggerated endothelin release in response to acute mental stress in patients with intermittent claudication. Angiology 53 (2002) 383-390
77. Quehenberger P., Bierhaus A., Fasching P., et al. Endothelin 1 transcription is controlled by nuclear factor-kappaB in AGE-stimulated cultured endothelial cells. Diabetes 49 (2000) 1561-1570
78. Leseth K.H., Adner M., Berg H.K., et al. Cytokines increase endothelin ETB receptor contractile activity in rat cerebral artery. Neuroreport 10 (1999) 2355-2359
79. White L.R., Juul R., Skaanes K.O., et al. Cytokine enhancement of endothelin ET(B) receptor-mediated contraction in human temporal artery. Eur J Pharmacol 406 (2000) 117-122
80. Borovikova L.V., Ivanova S., Zhang M., et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405 (2000) 458-462
81. Wang H., Yu M., Ochani M., Amella C.A., et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421 (2003) 384-388
82. Metz C.N., and Tracey K.J. It takes nerve to dampen inflammation. Nat Immunol 6 (2005) 756-757
83. Pavlov V.A., and Tracey K.J. The cholinergic anti-inflammatory pathway. Brain Behav Immun 19 (2005) 493-499
84. Andersson J. The inflammatory reflex-introduction. J Intern Med 257 (2005) 122-125
85. Czura C.J., and Tracey K.J. Autonomic neural regulation of immunity. J Intern Med 257 (2005) 156-166
86. Tracey K.J. The inflammatory reflex. Nature 420 (2002) 853-859
87. Saeed R.W., Varma S., Peng-Nemeroff T., et al. Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J Exp Med 201 (2005) 1113-1123
88. de Jonge W.J., van der Zanden E.P., The F.O., et al. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol 6 (2005) 844-851
89. Korte S.M., Koolhaas J.M., Wingfield J.C., et al. The Darwinian concept of stress: benefits of allostasis and costs of allostatic load and the trade-offs in health and disease. Neurosci Biobehav Rev 29 (2005) 3-38
90. Melamed S., Shirom A., Toker S., et al. Association of fear of terror with low-grade inflammation among apparently healthy employed adults. Psychosom Med 66 (2004) 484-491
91. Jeanmonod P., von Kanel R., Maly F.E., et al. Elevated plasma C-reactive protein in chronically distressed subjects who carry the A allele of the TNF-alpha-308 G/A polymorphism. Psychosom Med 66 (2004) 501-506
92. Kiecolt-Glaser J.K., Preacher K.J., MacCallum R.C., et al. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc Natl Acad Sci U S A 100 (2003) 9090-9095
93. von Kanel R., Dimsdale J.E., Patterson T.L., et al. Association of negative life event stress with coagulation activity in elderly Alzheimer caregivers. Psychosom Med 65 (2003) 145-150
94. Raikkonen K., Lassila R., Keltikangas-Jarvinen L., et al. Association of chronic stress with plasminogen activator inhibitor-1 in healthy middle-aged men. Arterioscler Thromb Vasc Biol 16 (1996) 363-367
95. Keltikangas-Jarvinen L., Raikkonen K., Hautanen A., et al. Vital exhaustion, anger expression, and pituitary and adrenocortical hormones: implications for the insulin resistance syndrome. Arterioscler Thromb Vasc Biol 16 (1996) 275-280
96. Nosadini R., Del Prato S., Tiengo A., et al. Insulin resistance in Cushing's syndrome. J Clin Endocrinol Metab 57 (1983) 529-536
97. Karnieli E., Cohen P., Barzilai N., Ish-Shalom Z., et al. Insulin resistance in Cushing's syndrome. Horm Metab Res 17 (1985) 518-521
98. Strasser R.H., Braun-Dullaeus R., Walendzik H., et al. Alpha 1-receptor-independent activation of protein kinase C in acute myocardial ischemia: mechanisms for sensitization of the adenylyl cyclase system. Circ Res 70 (1992) 1304-1312
99. di Paolo S., de Pergola G., Cospite M.R., et al. Beta-adrenoceptors desensitization may modulate catecholamine induced insulin resistance in human pheochromocytoma. Diabetes Metab 15 (1989) 409-415
100. Raza S.A., DeWitt R.T., Chen H., et al. Catecholamine excess in pheochromocytoma inducing insulin resistance. Endocr Pract 10 (2004) 149-152
101. Wiesner T.D., Bluher M., Windgassen M., et al. Improvement of insulin sensitivity after adrenalectomy in patients with pheochromocytoma. J Clin Endocrinol Metab 88 (2003) 3632-3636
102. Bluher M., Windgassen M., and Paschke R. Improvement of insulin sensitivity after adrenalectomy in patients with pheochromocytoma. Diabetes Care 23 (2000) 1591-1592
103. Brunner E.J., Hemingway H., Walker B.R., et al. Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: nested case-control study. Circulation 106 (2002) 2659-2665
104. Seematter G., Binnert C., Martin J.L., et al. Relationship between stress, inflammation and metabolism. Curr Opin Clin Nutr Metab Care 7 (2004) 169-173
105. Rotter V., Nagaev I., and Smith U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 278 (2003) 45777-45784
106. Senn J.J., Klover P.J., Nowak I.A., et al. Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 51 (2002) 3391-3399
107. Pickup J.C., Mattock M.B., Chusney G.D., et al. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 40 (1997) 1286-1292
108. Erren M., Reinecke H., Junker R., et al. Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. Arterioscler Thromb Vasc Biol 19 (1999) 2355-2363
109. Ridker P.M., Rifai N., Stampfer M.J., et al. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101 (2000) 1767-1772
110. Schmidt A.M., Hofmann M., Taguchi A., et al. RAGE: a multiligand receptor contributing to the cellular response in diabetic vasculopathy and inflammation. Semin Thromb Hemost 26 (2000) 485-493
111. Schmidt A.M., and Stern D.M. Receptor for age (RAGE) is a gene within the major histocompatibility class III region: implications for host response mechanisms in homeostasis and chronic disease. Front Biosci 6 (2001) D1151-D1160
112. Schmidt A.M., Yan S.D., Yan S.F., et al. The biology of the receptor for advanced glycation end products and its ligands. Biochim Biophys Acta 1498 (2000) 99-111
113. Bierhaus A., Humpert P.M., Morcos M., et al. Understanding RAGE, the receptor for advanced glycation end products. J Mol Med 83 (2005) 876-886
114. Harbuz M.S., Chover-Gonzalez A.J., and Jessop D.S. Hypothalamo-pituitary-adrenal axis and chronic immune activation. Ann N Y Acad Sci 992 (2003) 99-106
115. Jessop D.S., Richards L.J., and Harbuz M.S. Effects of stress on inflammatory autoimmune disease: destructive or protective?. Stress 7 (2004) 261-266
116. Straub R.H., Dhabhar F.S., Bijlsma J.W., et al. How psychological stress via hormones and nerve fibers may exacerbate rheumatoid arthritis. Arthritis Rheum 52 (2005) 16-26
117. Carpeggiani C., Emdin M., Bonaguidi F., et al. Personality traits and heart rate variability predict long-term cardiac mortality after myocardial infarction. Eur Heart J 26 (2005) 1612-1617
118. Tsuji H., Larson M.G., Venditti Jr. F.J., et al. Impact of reduced heart rate variability on risk for cardiac events: the Framingham Heart Study. Circulation 94 (1996) 2850-2855
119. Maser R.E., Mitchell B.D., Vinik A.I., et al. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care 26 (2003) 1895-1901
120. Vinik A.I., Maser R.E., Mitchell B.D., et al. Diabetic autonomic neuropathy. Diabetes Care 26 (2003) 1553-1579
121. Hayano J., Yamada A., Mukai S., et al. Severity of coronary atherosclerosis correlates with the respiratory component of heart rate variability. Am Heart J 121 (1991) 1070-1079
122. Gianaros P.J., Salomon K., Zhou F., et al. A greater reduction in high-frequency heart rate variability to a psychological stressor is associated with subclinical coronary and aortic calcification in postmenopausal women. Psychosom Med 67 (2005) 553-560
123. Bierhaus A., Zhang Y., Deng Y., et al. Mechanism of the tumor necrosis factor alpha-mediated induction of endothelial tissue factor. J Biol Chem 270 (1995) 26419-26432
124. Bierhaus A., Chen J., Liliensiek B., et al. LPS and cytokine activated endothelium. Semin Thromb Hemost 26 (2000) 571-588